drugset
drugset / Trial / NCT00829881

Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder

NCT00829881 ↗

Phase 1 Completed 16 enrolled P2D, Inc. National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will determine whether the drug betahistine increases focus and causes side effects in people with attention deficit hyperactivity disorder.

Timeline

Start
2009-01
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Betahistine Small molecule 200 mg Oral

Indications

attention deficit-hyperactivity disorder